Introduction: The outbreak of coronavirus disease 2019 (COVID-19) due to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has changed our daily basis practice. Some reports suggest that COVID-19 patients that undergo an endonasal endoscopic approach (EEA) should be considered potential superspreaders given the manipulation area during the procedures and aerosols production while drilling over the paranasal sinuses. The number of direct and indirect tests for COVID-19 diagnosis are limited in low-to-middle income countries (LMICs) and the time to obtain results may vary between 5 and 10 days. Consequently, screening processes for all patients that require an EEA are limited in most institutions in LMICs. Given this context, it is of utmost importance the development of different tools to decrease the transmission of the virus.